Eagle’s Eye View: The State of CV Health in the US
In this week’s View, Dr. Eagle comments on the recently published JACC Cardiovascular (CV) Statistics report which evaluates the management of CV risk factors in the United States. He then explores the use of semaglutide and its association with reduced hospital admissions and length of stay. Finally, Dr. Eagle examines the multicenter, multinational ADJUST-DVT study on the age-adjusted use of D-dimer cut-offs for patients with suspected deep vein thrombosis.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Dyslipidemia, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Vascular Medicine, Atherosclerotic Disease (CAD/PAD), Lipid Metabolism, Nonstatins, Acute Heart Failure, Echocardiography/Ultrasound, Hypertension
Keywords: Cholesterol, LDL, Coronary Artery Disease, Myocardial Infarction, Peripheral Arterial Disease, Heart Failure, Hypertension, Diabetes Mellitus, Obesity, Stroke, Overweight, Semaglutide, Length of Stay, Hospitals, Venous Thromboembolism, Prospective Studies, Fibrin, Venous Thrombosis, Ultrasonography, Pulmonary Embolism
